| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/23/2001 | WO2001060392A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1 |
| 08/23/2001 | WO2001060381A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 08/23/2001 | WO2001060379A1 Nucleoside analogs with carboxamidine modified monocyclic base |
| 08/23/2001 | WO2001060374A1 Use of paullone derivatives for making medicines |
| 08/23/2001 | WO2001060363A1 A method for synthesizing leflunomide |
| 08/23/2001 | WO2001060349A2 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof. |
| 08/23/2001 | WO2001060326A2 Cosmetic or pharmaceutical composition containing sesquiterpene lactone |
| 08/23/2001 | WO2001060324A1 Skin preparations for external use |
| 08/23/2001 | WO2001024764A3 Cell targeting compositions and methods of using the same |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001008704A3 Dendrimer-photosensitizer complexes for medical applications |
| 08/23/2001 | WO2001008529A3 Method for treating and preventing finger disorders |
| 08/23/2001 | WO2000078266A3 Interferon tau mutants and methods for making them |
| 08/23/2001 | WO2000074634A3 Methods and compositions for modulating cell proliferation and cell death |
| 08/23/2001 | WO2000059484A3 Use of arylalkanoylpyridazines |
| 08/23/2001 | WO2000044364A3 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant |
| 08/23/2001 | US20010016660 Reacting difunctional alkanes containing halogen or aliphatic or aromataic sulfonyloxide reactive functional groups with 4-aminopyrimidine derivative in presence of water and organic solvent (alcohols, glycols, polyglycols, mono or diethers) |
| 08/23/2001 | US20010016647 29 human secreted proteins |
| 08/23/2001 | US20010016583 Therapeutic application of pro-apoptotic benzodiazepines |
| 08/23/2001 | US20010016575 Antisense modulation of human MDM2 expression |
| 08/23/2001 | US20010016570 Bone disorders |
| 08/23/2001 | US20010016355 Genetic engineering |
| 08/23/2001 | US20010016346 Pedtidyl-prolyl cis-trans isomerase inhibitors and uses therefore |
| 08/23/2001 | EP1143944A3 Use of arylalkanoylpyridazines |
| 08/23/2001 | CA2400862A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors |
| 08/23/2001 | CA2400857A1 Skin preparations for external use |
| 08/23/2001 | CA2400619A1 Purine derivatives |
| 08/23/2001 | CA2400374A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1 |
| 08/23/2001 | CA2400290A1 A method for synthesizing leflunomide |
| 08/23/2001 | CA2400021A1 Aryloxyacetic acids for diabetes and lipid disorders |
| 08/23/2001 | CA2399198A1 Motilide compounds |
| 08/23/2001 | CA2398603A1 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | CA2397560A1 Use of paullone derivatives for making medicines |
| 08/23/2001 | CA2397233A1 Biarylcarboxamides |
| 08/23/2001 | CA2395854A1 Nucleoside analogs with carboxamidine-modified bicyclic base |
| 08/22/2001 | EP1125936A2 Aryl substituted azabenzimidazoles and their use in the treatment of HIV and AIDS related diseases |
| 08/22/2001 | EP1124980A2 Method for the production of quercetin and isoquercetin derivatives |
| 08/22/2001 | EP1124959A1 Cell surface molecule-induced macrophage activation |
| 08/22/2001 | EP1124850A1 12 human secreted proteins |
| 08/22/2001 | EP1124848A2 Transmembrane 4 proteins |
| 08/22/2001 | EP1124845A2 Phosphinate peptide analogs for the treatment of fibrotic disorders |
| 08/22/2001 | EP1124811A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/22/2001 | EP1124810A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/22/2001 | EP1124801A1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 08/22/2001 | EP1124794A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 08/22/2001 | EP1124779A1 Vitamin d analogues |
| 08/22/2001 | EP1124570A2 Novel neuropilin/growth factor binding and uses thereof |
| 08/22/2001 | EP1124560A1 Use of antifungal agents for treating scleroses |
| 08/22/2001 | EP1124535A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
| 08/22/2001 | EP1085811A4 Broad specificity dna damage endonuclease |
| 08/22/2001 | EP0904042A4 Cosmetic composition for rejuvenation of skin without skin irritation |
| 08/22/2001 | EP0777653B1 Dihygropyridine derivatives as bradykinin antagonists |
| 08/22/2001 | EP0697880B1 Inhibition of leukocyte adhesion |
| 08/22/2001 | CN1309666A Polymer composition of glucuronic acid glucosan |
| 08/22/2001 | CN1309663A Anti-angiogenic proteins and methods of use thereof |
| 08/22/2001 | CN1309660A Phosphinous and phosphonic acid derivs. used as medicaments |
| 08/22/2001 | CN1309657A Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of growth hormone release inhibiting factor receptors |
| 08/22/2001 | CN1309641A Quinoline derivs. |
| 08/22/2001 | CN1309640A Quinoline derivs. |
| 08/22/2001 | CN1309563A Use of 1-(aminoalkyl)-3-quinoxaline-2-one derives for preparation of compounds having antioxidant action |
| 08/22/2001 | CN1308964A Process for preparing spirulina tablet |
| 08/22/2001 | CN1308961A Medicine for treating dermatopathy by photochemical therapy |
| 08/22/2001 | CN1308942A Tea for beautifying face and lossing weight |
| 08/22/2001 | CN1308933A Skin-care ecological nutritive cream of forest frog's oviduct fat and its preparing process |
| 08/22/2001 | CN1069834C Medical powder for treating acne |
| 08/22/2001 | CN1069830C Exterior use medical ointment for treating foot disorder and its preparing process |
| 08/22/2001 | CN1069824C Multi-effect bath lotion contg. iodine |
| 08/21/2001 | US6277989 Quinazoline derivatives as medicaments |
| 08/21/2001 | US6277882 Skin disorders |
| 08/21/2001 | US6277881 Turmeric as an anti-irritant in compositions containing hydroxy acids or retinoids |
| 08/21/2001 | US6277876 Antiinflammatory agents; prevent tissue degradation |
| 08/21/2001 | US6277868 Bactericides; skin disorders |
| 08/21/2001 | US6277839 Antiinflammatory agents, antipyretics, analgesics; side effect reduction |
| 08/21/2001 | US6277837 Treatment of psoriasis, leukemia, cancers, osteoporosis |
| 08/21/2001 | US6277824 Enhancing or inhibiting cadherin-mediated functions comprising a his-ala-val sequence binding motif, an peptidomimetic or an antibody that binds to such a motif |
| 08/21/2001 | US6277387 Use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF αantagonist in a cosmetic, pharmaceutical or dermatological composition and composition obtained |
| 08/21/2001 | US6277357 Ketotricyclo[5.2.1.0]decane derivatives |
| 08/21/2001 | CA2319308C Pharmaceutical agents |
| 08/21/2001 | CA2207348C Benzimidazole derivatives |
| 08/16/2001 | WO2001059137A1 Method for remodelling cell wall polysaccharide structures in plants |
| 08/16/2001 | WO2001059106A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 08/16/2001 | WO2001059072A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/16/2001 | WO2001059071A2 Methods of preparing and using a viral vector library |
| 08/16/2001 | WO2001058956A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | WO2001058949A2 Heterologous polypeptide of the tnf family |
| 08/16/2001 | WO2001058927A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 08/16/2001 | WO2001058918A2 Oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments |
| 08/16/2001 | WO2001058907A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058906A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058902A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058900A1 1h-imidazopyridine derivatives |
| 08/16/2001 | WO2001058899A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 08/16/2001 | WO2001058897A1 Benzthiazoles as tnf and pde-iv inhibitors |
| 08/16/2001 | WO2001058896A1 Benzoxazole derivatives as tnf and pde iv inhibitors |
| 08/16/2001 | WO2001058895A1 Benzofuran carboxamides and their therapeutic use |
| 08/16/2001 | WO2001058889A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 08/16/2001 | WO2001058885A1 Oxazolidinone thioamides with piperazine amide substituents |
| 08/16/2001 | WO2001058881A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 08/16/2001 | WO2001058879A1 2-phenylcarbamoyl-benzimidazoles |
| 08/16/2001 | WO2001058878A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury |